The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS
Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
These initiatives aim to improve access to healthcare for rare disease patients
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
